arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Oculis Holding AG

OCS Health Care Biotechnology: Pharmaceutical Preparations
$11.96
▼ -0.9% Today
as of Aug 5, 16:52 ET
Last 30 days +0.58% Jun 26 → Aug 05
$10.58 $11.53 $12.48 $13.43 $14.38 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$11.67
High
$12.04
Low
$11.17
Volume
$869,281
Avg Vol
$242,646
Mkt Cap
$689M
P/E (TTM)
—
Beta
—
52w High
$34.48
52w Low
$11.17
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 9 items

Aug 5 · 13:33 GuruFocus.com
Earnings To Watch: Oculis Holding AG (OCS) Reports Q2 2026 Result
Aug 3 · 08:00 PR GlobeNewswire
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
Jul 8 · 20:05 PR GlobeNewswire
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
▸ Show all 9 press releases & news Free account →

Overview

52-week range
$11
$34
3% of range
Avg surprise (last 3)
-30.3%
Avg reaction (last 2)
+0.8%
100% positive
Latest IV / EM
242%
EM ±41.7% · $13 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.77$-0.70$-0.63$-0.56$-0.49 Actual $-0.77Est $-0.51Actual $-0.59Est $-0.53Actual $-0.63Est $-0.49 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.63 $-0.49 -28.6% +18.2% +0.0% earnings
Thu Aug 21, 2025Jun/2025 $-0.59 $-0.53 -11.3% — — earnings
Thu May 8, 2025Mar/2025 $-0.77 $-0.51 -51.0% — +1.5% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 20, 2026Jun/2026OTHER -$0.48-$0.59 +18.6%

Implied volatility — last 90 days

52%192%333%473%614% Jun 08 — IV 191% · EM ±25.2%Jun 09 — IV 363% · EM ±45.5%Jun 10 — IV 389% · EM ±46.0%Jun 12 — IV 467% · EM ±47.8%Jun 15 — IV 267% · EM ±19.3%Jun 16 — IV 362% · EM ±21.4%Jun 17 — IV 615% · EM ±25.7%Jun 19 — IV 184% · EM ±40.6%Jun 22 — IV 214% · EM ±44.6%Jun 23 — IV 52% · EM ±10.7%Jun 24 — IV 214% · EM ±42.8%Jun 25 — IV 224% · EM ±43.9%Jun 26 — IV 218% · EM ±41.7%Jun 29 — IV 224% · EM ±39.7%Jun 30 — IV 117% · EM ±20.2%Jul 01 — IV 261% · EM ±43.6%Jul 02 — IV 150% · EM ±24.2%Jul 03 — IV 153% · EM ±23.9%Jul 06 — IV 157% · EM ±21.7%Jul 07 — IV 276% · EM ±36.5%Jul 08 — IV 288% · EM ±36.1%Jul 09 — IV 324% · EM ±38.3%Jul 10 — IV 329% · EM ±36.3%Jul 13 — IV 451% · EM ±37.6%Jul 14 — IV 444% · EM ±32.1%Jul 15 — IV 543% · EM ±32.0%Jul 21 — IV 180% · EM ±41.8%Jul 22 — IV 191% · EM ±43.7%Jul 23 — IV 198% · EM ±44.6%Jul 24 — IV 228% · EM ±50.5%Jul 27 — IV 232% · EM ±48.5%Jul 28 — IV 241% · EM ±49.3%Jul 29 — IV 251% · EM ±50.3%Jul 30 — IV 248% · EM ±48.6%Jul 31 — IV 231% · EM ±44.2%Aug 03 — IV 126% · EM ±22.3%Aug 04 — IV 242% · EM ±41.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in